ArticleBMC medical imaging2025
A novel strategy for enhanced schizophrenia detection using established CNN architectures.
Article in BMC medical imaging, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Schizophrenia, a complex psychotic condition, is challenging to diagnose due to its reliance on clinical assessments and behavioral evaluations. Neuroimaging studies, particularly structural MRI, have revealed reductions in grey matter volume in brain regions such as the temporal lobe and insula. This study combines deep learning and neuroimaging for precise automatic detection of schizophrenia. Using T1-weighted coronal MRI data from three publicly accessible datasets (MCICShare, COBRE, UCLA), a DeepLabv3+ model with ResNet50-based segmentation was employed to isolate the temporal lobe and insula, achieving segmentation accuracies of 96% and 97%, respectively. Enhanced visualization of isolated regions through color-to-grayscale conversion distinguished schizophrenia patients from controls, achieving an AUC of 0.99. Our study specifically focuses on the regions critically linked to both cognitive and emotional dysfunctions in schizophrenia. These results advance the literature by demonstrating improved diagnostic performance and reliability compared to traditional clinical assessments and earlier imaging-based methods.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.